Genmab | GEN - Ebit





Ebit Cambio Fecha
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Almirall EUR 71.55M 41.32M 2026-06
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.61B 777M 2026-06
argenx SE USD 486M 7M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Bayer EUR 755M 2.77B 2026-06
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Demant DKK 2.12B 58M 2026-06
Exelixis USD 268.42M 20.01M 2026-09
Fresenius Medical Care EUR 480.55M 212.55M 2026-06
Genmab DKK 407M 221M 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
GN Store Nord DKK 58M 126M 2026-06
GRIFOLS EUR 428M 179M 2026-06
Hikma Pharmaceutical USD 348M 31M 2025-12
Insmed USD -81.83M 19.48M 2026-09
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Lonza CHF 673M 54M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 5.14B 411M 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
UCB EUR 1.29B 571M 2025-12